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Summary
Malaria parasite sporozoites prepare for transmission
to a mammalian host by upregulation of UIS (Upregu-
lated in Infectious Sporozoites) genes. A number of
UIS gene products are essential for the establishment
of the intrahepatocytic niche. However, the factors
that regulate the expression of genes involved in gain
of infectivity for the liver are unknown. Herein, we
show that a conserved Plasmodium sporozoite low-
complexity asparagine-rich protein, SAP1 (Sporozoite
Asparagine-rich Protein 1), has an essential role in
malaria parasite liver infection. Targeted deletion of
SAP1 in the rodent malaria parasite Plasmodium
yoelii generated mutant parasites that traverse and
invade hepatocytes normally but cannot initiate liver-
stage development in vitro and in vivo. Moreover,
immunizations with Pysap1(-) sporozoites confer
long-lasting sterile protection against wild-type
sporozoite infection. Strikingly, lack of SAP1 abol-
ished expression of essential UIS genes including
UIS3, UIS4 and P52 but not the constitutively
expressed genes encoding, among others, sporozoite
proteins CSP and TRAP. SAP1 localization to the cell
interior but not the nucleus of sporozoites suggests
its involvement in a post-transcriptional mechanism
of gene expression control. These ﬁndings demon-
strate that SAP1 is essential for liver infection possi-
bly by functioning as a selective regulator controlling
the expression of infectivity-associated parasite
effector genes.
Introduction
The ﬁrst step of malaria transmission is the injection
of sporozoites into a mammalian host by an anopheline
mosquito bite (Vanderberg and Frevert, 2004; Amino
et al., 2006). Initially, sporozoites form in mosquito midgut
oocysts and subsequently invade and reside inside the
salivary glands (reviewed in Matuschewski, 2006). In the
mosquito salivary glands, sporozoites gain infectivity that
is critical to support their transmission and life cycle
progression in the mammalian liver (Vanderberg, 1974;
1975). Previous work has demonstrated that gain of infec-
tivity is accompanied by extensive differential upregula-
tion of unique gene products called UIS (Upregulated
in Infectious Sporozoites) (Matuschewski et al., 2002).
Indeed, UIS genes were shown to be essential for malaria
parasite liver infection. UIS3 and UIS4 (Mueller et al.,
2005a,b; Tarun et al., 2007) are proteins of the parasito-
phorous vacuole membrane (PVM), the principal host–
parasite interface during cell infection (Mueller et al.,
2005b; Mikolajczak et al., 2007a). Deletion of UIS3 and
UIS4 leads to complete early arrest of liver-stage devel-
opment inside the PVM (Mueller et al., 2005a,b; Tarun
et al., 2007). Recently, it was shown that UIS3 interacts
with liver fatty acid-binding protein (L-FABP) indicating a
potential role of this protein in fatty acid uptake from the
host hepatocyte (Mikolajczak et al., 2007a). Simultaneous
deletion of the UIS gene P52 (also called P36p), a puta-
tive GPI-anchored protein, and a non-UIS gene, P36,a
putative secreted protein, renders sporozoites unable to
form a PVM during infection and leads to complete devel-
opmental arrest at the early stage of hepatocyte infection
(van Dijk et al., 2005; Ishino et al., 2005a; Labaied et al.,
2007). Therefore, a number of UIS proteins critically con-
tribute to establishing the intracellular parasitic niche
either by the formation or modiﬁcation of the host–
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2006). However, it remains unknown what factors regu-
late the expression of UIS genes and consequently liver
infectivity of sporozoites. Herein, we have identiﬁed
a cytoplasmic low-complexity asparagine-rich protein,
SAP1 (Sporozoite Asparagine-rich Protein 1) that is
essential for liver infection possibly by means of regulat-
ing the expression of effector proteins such as P52, UIS3
and UIS4. Targeted deletion of PySAP1 generated mutant
parasites that traverse host cells, invade hepatocytes and
form a PVM but cannot initiate liver-stage development
and consequently completely lose mammalian infectivity
in vivo. Drastically reduced transcript levels of liver
infection-associated UIS genes in SAP1-deﬁcient sporo-
zoites in combination with SAP1’s putative cytoplasmic
localization suggest a post-transcriptional regulation of
gene expression function of SAP1 in malaria parasite liver
infection.
Results
SAP1 is a conserved Plasmodium sporozoite protein
with an asparagine-rich low-complexity domain
We searched for putative cytoplasmic proteins that are
highly expressed in sporozoites but not in blood stages
because they might uniquely contribute to regulation
of sporozoite infectivity. SAP1 was ﬁrst identiﬁed as a
sporozoite-expressed gene in a suppression subtractive
hybridization (SSH) screen of Plasmodium yoelii salivary
gland sporozoites versus blood-stage merozoites (desig-
nated S22, sporozoite-speciﬁc gene 22) (Kaiser et al.,
2004).PySAP1(geneidentiﬁerPY03269)hasorthologues
in other Plasmodium species including the human malaria
parasite P. falciparum (gene identiﬁer PF11_0480)
(Carlton et al., 2002; Gardner et al., 2002). Alignment of
PfSAP1 and PySAP1 revealed that the PySAP1 open
reading frame (ORF) was incomplete. Bioinformatics
analysis and direct sequencing revealed that the PySAP1
coding sequence was dispersed over two unassembled
sequence contigs (described in Text S1 in Supplementary
material). We conﬁrmed the overlap between the two
contigs encoding PySAP1 by genomic PCR and reverse
transcription polymerase chain reaction (RT-PCR) analy-
sis.Thecorrectstartandstopcodonsaswellasthecorrect
exon–intron organization were also conﬁrmed by RT-PCR
analysis of salivary gland sporozoite RNA (Fig. 1A). The
correctedPySAP1ORFnucleotidesequence(9723nucle-
otides) and the predicted protein sequence (3240 amino
acids) were deposited in NCBI GenBank (Accession No.:
EU652769, Text S1). PySAP1 encodes a large putative
proteinwithapredicted370 kDamolecularmass.PySAP1
has one large exon followed by two small exons (Fig. 1A).
Signal sequences, transmembrane domain(s), enzymatic
or structural motifs were not identiﬁable in any of the
predicted Plasmodium SAP1 protein sequences exam-
ined. SAP1 proteins are characterized by the presence of
an extended internal asparagine-rich low-complexity
domain, with an asparagine content of 27% in P. yoelii
ﬂankedbypredictedglobulardomainswithlowasparagine
content (Fig. 1B). Interestingly, these (N)- and (C)-terminal
regions are highly conserved among Plasmodium
species. The PySAP1 N-terminus shares 70% amino acid
sequence identity with the N-terminus of the P. falciparum
orthologue, and the PySAP1 C-terminus shares 89%
amino acid sequence identity with C-terminus of PfSAP1
(Fig. 1B). However, the overall amino acid sequence iden-
tityofSAP1betweenP. yoeliiandP. falciparumisonly26%
due to the sequence divergence in the asparagine-rich
domain (Fig. 1B).
Sporozoite-speciﬁc expression proﬁle of PySAP1
and PfSAP1
RT-PCR analysis revealed that PySAP1 is transcribed
in oocyst and salivary gland sporozoites (Fig. 1C). As
expected from the results of the previous SSH screen
(Kaiser et al., 2004), no transcripts were detected in
unsynchronized mixed blood stages (Fig. 1C). A similar
expression pattern of SAP1 was observed in P. falciparum
oocyst and salivary gland sporozoites. No transcripts
were detected in mixed blood stages. (Fig. 1D). There-
fore, the sporozoite-speciﬁc expression proﬁle of PfSAP1
is similar to the expression proﬁle of PySAP1.
Localization of PySAP1
To determine the cellular localization of SAP1, we gener-
ated rabbit polyclonal antisera against a peptide in the
C-terminus of PySAP1 and tested the antisera in immu-
noﬂourescence assays (IFAs) using P. yoelii sporozoites.
A speciﬁc sporozoite-internal staining that excluded the
nucleus and was distinct from circumsporozoite (CS)
protein staining was observed (Fig. 2). SAP1 localization
appeared uneven and clustered within the sporozoite
cytoplasm. Its localization appeared also distinct when
compared with cytoplasmic heat shock protein (HSP70)
staining, which was induced by incubation of the sporo-
zoites at 37°C for 1 h (Fig. 2). SAP1 staining was only
observed in sporozoites after membrane permeabiliza-
tion, indicating that SAP1 localizes exclusively to the inte-
rior of the sporozoite. Together, the data suggest that
SAP1 localizes to the cytoplasm, intracellular organelles
or other structures within the cytoplasm as predicted by
the lack of a secretory signals in the SAP1 sequence.
Pre-immune sera did not show reactivity with sporozoites
(data not shown).
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in blood and mosquito stages
Targeted gene deletion of PySAP1 was conducted by
double-cross-over homologous recombination to replace
the majority of the coding sequence with the TgDHFR/TS
selection marker cassette (Fig. 3A) (Menard and Janse,
1997). Deletion-speciﬁc genomic PCR analysis conﬁrmed
the successful double-cross-over recombination event
and the successful isolation of a Pysap1(-) parasite clone
with pure gene deletion background (Fig. 3B). Therefore,
PySAP1 was successfully deleted in the erythrocytic
stages with no observed deﬁciency of blood-stage devel-
opment (data not shown). In addition, the morphology of
male and female gametocytes in thin infected-blood
smears and male gamete exﬂagellation in wet mounts of
infected blood were indistinguishable from P. yoelii wild-
type (WT) parasites (data not shown). Transmission of
Pysap1(-) parasites to mosquitoes resulted in normal
midgut infection and oocyst development. Pysap1(-)
oocyst sporozoites developed in a similar manner as
PyWT oocyst sporozoites (Table S1 in Supplementary
material). Importantly, Pysap1(-) sporozoites accumu-
lated in the salivary glands in numbers comparable to
WT, indicating normal salivary gland infection (Table S1).
RT-PCR analysis conﬁrmed the absence of PySAP1 tran-
scripts in Pysap1(-) sporozoites (Fig. 3C). IFAs with
the anti-SAP1 antisera were negative, conﬁrming that
Pysap1(-) sporozoites do not express SAP1 (Fig. 2). The
data give further support to the speciﬁcity of the SAP1
antisera. We conducted all initial experiments with two
independent clones of Pysap1(-) that were identical in
their phenotypes (data not shown). Thereafter, experi-
ments were conducted with a single Pysap1(-) clone.
Fig. 1. SAP1 gene structure, protein structure, conservation among Plasmodium species and transcriptional proﬁling.
A. A schematic representation of the SAP1 gene organization: arrows show the locations of primers used for RT-PCR to identify the start and
stop codons as well as exon 2 and exon 3.
B. Alignment of the putative PySAP1 with PbSAP1 and PfSAP1. The asparagine-rich regions are shown as light grey boxes bordered by
non-asparagine-rich N- and C- termini shown as dark grey boxes. Total amino acid sequence identities to PySAP1 are shown to the right and
amino acid sequence identities between the N-termini and the C-termini are shown inside their respective boxes. Per cent (%) asparagine
content is shown only for PySAP1.
C. RT-PCR analysis of RNA isolated from P. yoelii sporozoites shows the expression of PySAP1 in ooSPZ (oocyst sporozoites) and sgSPZ
(salivary gland sporozoites) but not in mixed blood stages (mixedBS). PyCS (circumsporozoite protein) is a positive RT-PCR control for
sporozoite expression and PyHSP70 is a positive RT-PCR control for mixed blood stages.
D. RT-PCR analysis of different P. falciparum life cycle stages shows expression of PfSAP1 in ooSPZ and sgSPZ but a lack of expression in
blood stages (mixedBS).
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infection and elicit sterile protection against PyWT
sporozoite challenge
We tested the infectivity of PySAP1-deﬁcient salivary
gland sporozoites in susceptible BALB/c mice. Mosquito
bite experiments with more than 50 Pysap1(-)-infected
mosquitoes/mouse did not result in blood-stage infection
(data not shown). Strikingly, intravenous (iv) injection of
escalating doses of Pysap1(-) salivary gland sporozoites
did not lead to blood-stage parasitaemia, tested daily by
blood smears until day 14 post infection (Table 1). Even
with extremely high doses of more than 2 million sporo-
zoites no subsequent blood-stage parasitaemia was
observed. This highest dose corresponded to a ~200 000-
fold increase over the minimal infectious dose of PyWT
sporozoites administered to BALB/c mice by iv injection
(Belmonte et al., 2003). Hence, we conclude that PySAP1
is essential for parasite pre-erythrocytic stage functions
after transmission from the mosquito to the mammalian
host.
We next tested whether Pysap1(-) salivary gland
sporozoite immunization of mice can induce sterile pro-
tection against PyWT sporozoite challenge. Four groups
of BALB/c mice were immunized iv with three doses of
10 000 Pysap1(-) salivary gland sporozoites, in 2-week
intervals (Table 2). The ﬁrst immunization group (group I)
was challenged by iv injection of 10 000 PyWT sporozoi-
Fig. 2. SAP1 is localized to the cell interior of Plasmodium sporozoites. Immunoﬂuorescence assays on air-dried PyWT or Pysap1(-) salivary
gland sporozoites show the predicted internal localization of SAP1 in PyWT, which is detected only after sporozoite permeabilization with
saponin (perm.). SAP1 staining was not detected in Pysap1(-) sporozoites after sporozoite permeabilization. Note the absence of SAP1
staining in the nucleus of PyWT sporozoites. Scale bar is 5 mm.
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immunization groups (groups II and III) were challenged
by iv injection of 10 000 PyWT sporozoites 30 and
210 days after the last immunization dose. The mice of
group III were then challenged by PyWT erythrocytic
stages 2 weeks after the last challenge with either 103 or
106 asexual blood stages injected iv or intraperitoneally
(ip) into ﬁve mice each respectively (data not shown). The
fourth group (group IV) was challenged by infectious mos-
quito bite 45 and 210 days after the last immunization
dose. All mice were protected when challenged with
PyWT sporozoites and did not develop any blood-stage
infection (Table 2). However, mice challenged with blood-
stage parasites developed blood-stage parasitaemia after
Fig. 3. Targeted deletion of PySAP1.
A. Schematic representation of the
replacement strategy to generate Pysap1(-)
parasites. The endogenous PySAP1 genomic
locus is targeted with a replacement fragment
containing the 5′ and 3′ sequence within exon
1o fPySAP1 ﬂanking the Toxoplasma gondii
DHFR/TS-positive selection marker.
Diagnostic wild type-speciﬁc or
integration-speciﬁc test amplicons are
indicated by lines.
B. PCR genotyping shows the gene
replacement using oligonucleotide primer
combinations that can only amplify from the
recombinant locus (Test 1 and Test 2). The
wild type-speciﬁc PCR reaction (WT) conﬁrms
the absence of wild-type parasites in the
clonal Pysap1(-) parasites.
C. RT-PCR analysis (35 cycles) shows the
loss of PySAP1 transcripts in RNA isolated
from Pysap1(-) sgSPZs. The PySAP1-speciﬁc
amplicon used for the analysis is shown
above in (A) as the wild type (WT) test.
PyCSP was used as a positive control.
Table 1. PySAP1-deﬁcient sporozoites are completely attenuated and do not cause blood-stage infection in BALB/c mice.
No. of injected sporozoites
Pysap1(-)P y WT
Infected Pre-patent period
a Infected Pre-patent period
a
20 ND ND 2/2 4 days
100 ND ND 6/6 4 days
10 000 0/30 – 8/8 3 days
100 000 0/15 – 3/3 2.5 days
500 000 0/8 – ND ND
1 000 000 0/4 – ND ND
> 2 000 000 0/3 – ND ND
a. The period (in days) between sporozoite infection and the detection of erythrocytic stages in blood smears.
ND, not done.
Table 2. Immunization with Pysap1(-) sporozoites confers sterile protection against wild-type sporozoite challenge.
Group
Primary dose
(days of booster dose)
Challenge dose/
days after last boost
No. protected/
No. challenged
a
Mean pre-patent
period (days)
I 10 000 (14, 28) 10 000/7 9/9 -
II 10 000 (14, 28) 10 000/(30)/(210) 15/15/15 -/-
III 10 000 (14, 28) 10 000/(30)/(210) 10/10/10 -/-
IV 10 000 (14, 28) MB
b/(45)/(210) 5/5/5 -/-
a. Each immunization group had an age-matched naïve control group (minimum three mice) that all became patent at day 3 after each PyWT
sporozoite challenge.
b. Infection through mosquito bite (MB) by allowing a minimum of 10 PyWT female infected mosquitoes, with midgut oocyst infectivity higher than
90%, to bite one mouse for at least 10 min.
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Pysap1(-) salivary gland sporozoite immunizations
induce stage-speciﬁc sterile immunity against subsequent
PyWT sporozoite infection but not against asexual blood-
stage infection.
Pysap1(-) sporozoites traverse and invade hepatocytes
normally but suffer an early liver-stage developmental
arrest in vitro
Failure of mutant salivary gland sporozoites to induce
blood-stage infection in mice can be due to distinct knock-
out phenotypes (reviewed in Mikolajczak and Kappe,
2006). Pysap1(-) salivary gland sporozoites displayed
continuous gliding motility that was undistinguishable
from PyWT, tested on glass slides by direct microscopic
examination (Vanderberg, 1974) (data not shown). There-
after, we tested the cell-traversal capacity of Pysap1(-)
salivary gland sporozoites using a cell-wounding assay
(Vanderberg et al., 1990; Mota et al., 2001). Pysap1(-)
sporozoites traversed hepatocytes and wounded cells at
a rate comparable to PyWT sporozoites (Fig. 4A). In order
to identify and characterize the deﬁciency of Pysap1(-)
sporozoites in completing pre-erythrocytic infection, we
conducted in vitro assays with the hepatoma cell line
HepG2-CD81 which sustains productive P. yoelii sporozo-
ite infection and liver-stage development (Silvie et al.,
2006). Intrahepatocytic parasites were quantiﬁed by dif-
Fig. 4. Pysap1(-) parasites traverse and invade hepatocytes but fail to complete liver-stage development in vitro.
A. Graph shows the per cent of dextran-positive hepatoma cells as an indication of sporozoites cell-traversal activity. No signiﬁcant difference
can be detected between Pysap1(-) and wild type (PyWT).
B. Graph shows the number of intracellular liver stages, determined by differential permeabilization, at different time points post sporozoite
infection. The number of Pysap1(-) intracellular parasites is similar to PyWT at 1 and 6 h post infection but drastically decreases at 12 and
18 h. At 24 h virtually no Pysap1(-) liver stages survived. Note that the number of WT liver stages in this assay initially decreases but
stabilizes after 12 h.
C. Immunoﬂuorescence assays show liver-stage development at different time points after sporozoite infection. Pysap1(-) intracellular
parasites (CSP and HSP70 staining in green) do not express the PVM marker UIS4 (red) and arrest in development. Growth-arrested
Pysap1(-) liver stages shown at 24 h post infection were detected rarely in this assay. Scale bar is 5 mm.
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vitro infection (pi) using ﬂuorescence microscopy. Inter-
estingly, at 1 h pi the number of Pysap1(-) intracellular
parasites was similar to PyWT infections, but Pysap1(-)
intracellular liver-stage numbers gradually decreased in
comparison with PyWT infections at 6 h and 12 h pi
(Fig. 4B). Pysap1(-) intracellular parasite numbers then
sharply decreased at 18 h pi and at 24 h pi there were
almost no intracellular parasites, when compared with
PyWT (Fig. 4B). Most importantly, intrahepatocytic
Pysap1(-) parasites failed to grow and develop. They
appeared smaller and deﬁcient in their transformation to
liver-stage trophozoites when compared with PyWT liver
stages (Fig. 4C). Surprisingly, immunostaining of the
PVM-resident protein UIS4 showed that it was not
detected in Pysap1(-) parasites at all time points tested,
whereas in PyWT liver stages a UIS4 positive PVM stain-
ing pattern was observed at all time points later than 1 h
pi (Fig. 4C). Evidently, Pysap1(-) sporozoites infect host
hepatocytes but suffer growth arrest early during liver-
stage development in vitro, suggesting that an early
growth defect causes the lack of Pysap1(-) sporozoite
infectivity to mice.
Electron microscopic analysis of intrahepatocytic
Pysap1(-) sporozoites
Intracellular malaria parasites need a PVM for develop-
ment (reviewed in Mikolajczak and Kappe, 2006). There-
fore, we examined whether the observed lack of UIS4 in
intracellular Pysap1(-) parasites indicated a possible deﬁ-
ciency in PVM formation. We performed an electron
microscopic analysis of intracellular WT and Pysap1(-)
parasites 1 h after infection of HepG2-CD81 cells. Intrac-
ellular Pysap1(-) parasites were able to form a PVM
(Fig. 5). Out of 15 intrahepatocytic Pysap1(-) parasites
evaluated by EM, 4 exhibited a PVM and 11 appeared free
in the cytoplasm. The latter may represent sporozoites in
the process of cell traversal. However, it is also possible
that Pysap1(-) sporozoites form a PVM but less efficiently
than PyWT.
UIS gene products are depleted in
Pysap1(-) sporozoites
Despite of the presence of a PVM we noted the lack of
PyUIS4 in Pysap1(-) liver stages (Fig. 4C). PyUIS4 is
normally expressed in sporozoite secretory organelles as
well as the liver-stage PVM and is essential for malaria
parasite liver-stage development (Mueller et al., 2005b).
To test whether PyUIS4, as well as other proteins, is
expressed in Pysap1(-) sporozoites prior to hepatocyte
invasion, we performed IFAs to test UIS4, UIS3 and MTIP
(Bergman et al., 2003) expression in Pysap1(-) and
PyWT salivary gland sporozoites. In PyWT sporozoites
we detected expression of each protein (Fig. 6A). In
contrast, we did not detect expression of UIS4 or UIS3
in Pysap1(-) sporozoites but did detect MTIP staining
(Fig. 6A). To test whether this expression pattern is due to
a reduction in UIS4 and UIS3 transcript abundance, which
would potentially indicate transcript degradation (Parker
and Sheth, 2007), we performed RT-PCR analysis on
Pysap1(-) salivary gland sporozoite cDNA. Strikingly, we
observed a severe reduction of PyUIS4 and PyUIS3
(Mueller et al., 2005a,b) transcript abundance (Fig. 6B
and C). Furthermore, we saw a decrease in P52 (van Dijk
et al., 2005; Ishino et al., 2005a,b; Labaied et al., 2007)
transcript abundance as well as the transcripts of two
uncharacterized UIS genes, UIS2 (putative secreted
phosphatase) and UIS28 (putative secreted lipase)
Fig. 5. Pysap1(-) liver stages form a
parasitophorous vacuole membrane (PVM).
Electron microscopic analysis establishes that
intrahepatocytic Pysap1(-) parasites form a
PVM.
A. Transversal section of a PyWT parasite
within a HepG2-CD81 cell 1 h post infection.
The PVM is indicated.
B. Transversal section of Pysap1(-)
sporozoite 1 h post infection in HepG2-CD81.
The PVM is indicated.
IMC, inner membrane complex; Mi,
microneme; N, nucleus; PPM, parasite
plasma membrane; PVM, parasitophorous
vacuole membrane; Mt, mitochondrion.
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transcript abundance for genes that are involved in
sporozoite functions prior to PVM formation and liver-
stage development appeared not signiﬁcantly reduced in
Pysap1(-) sporozoites (Fig. 6B and C). These genes
included CSP, TRAP (reviewed in Kappe et al., 2004;
Baldacci and Menard, 2004), SPECT1 (Ishino et al.,
2004), SPECT2 (Ishino et al., 2005b) and S4/CELTOS
(Kaiser et al., 2004, Kariu et al., 2006). Therefore, lack of
PySAP1 in sporozoites has a selective negative impact on
UIS gene expression in P. yoelii.
Discussion
Successful hepatocyte infection and liver-stage develop-
ment by the malaria parasite is dependent on establish-
ment of a PVM as the functional host–parasite interface.
Some UIS gene products uniquely expressed in salivary
gland sporozoites and localized to the PVM in liver stages
play essential roles in intrahepatocytic parasite survival
(Mueller et al., 2005a,b; Mikolajczak et al., 2007a; Tarun
et al., 2007). However, factors that allow salivary gland
sporozoites lying-in-wait in the mosquito salivary glands
to initiate a co-ordinated switch to mammalian host infec-
tion by differential expression of UIS have not been
identiﬁed. Our work identiﬁes SAP1 as such a potential
factor. PySAP1 is the ﬁrst identiﬁed cytoplasmic Plasmo-
dium protein with an essential function for pre-erythrocytic
stages. It has a large internal asparagine-rich low-
complexity domain. Low-complexity domains are fre-
quently found in Plasmodium proteins (Aravind et al.,
2003). This is partially the consequence of the high A/T
nucleotide content in the Plasmodium genome (Pizzi
and Frontali, 2001; Singh et al., 2004). Low-complexity
domains in Plasmodium proteins were hypothesized to be
an evolutionary by-product with no signiﬁcant function in
the biology of the malaria parasite (Xue and Forsdyke,
2003). In contrast, low-complexity proteins have been
Fig. 6. Essential UIS proteins are depleted in Pysap1(-) sporozoites.
A. Immunoﬂuorescence assays on air-dried PyWT salivary gland sporozoites show expression of CSP and HSP70 (red), MTIP, UIS3 and UIS4
(green). Pysap1(-) sporozoites exhibit MTIP, HSP70 and CSP staining but lack UIS3 and UIS4. Scale bar is 5 mm.
B. Twenty-seven-cycle non-quantitative RT-PCR analysis with RNA isolated from PyWT and Pysap1(-) salivary gland sporozoites showing
expression of UIS transcripts in WT sporozoites and the depletion of UIS transcripts in Pysap1(-) sporozoites (right). Transcripts of non-UIS
genes that are essential for sporozoites prior to or in hepatocyte infection appear unaffected (left).
C. Thirty-ﬁve-cycle non-quantitative RT-PCR analysis, with the same RNA used in (B). At higher PCR cycle number UIS transcripts are
detected.
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genic bacterial strains (Nandi et al., 2003). The low-
complexity domain of SAP1 is ﬂanked by two highly
conserved non-asparagine-rich N- and C-terminal
domains. The level of conservation in these domains is
high among SAP1 proteins from distinct Plasmodium
species, indicating that they represent functionally impor-
tant regions. Pysap1(-) salivary gland sporozoites show
extremely reduced transcript abundance for UIS3, UIS4
and P52 but not SPECTs, TRAP and CSP, indicating a
selective mechanism of UIS transcript depletion. It will be
interesting to determine whether transcript abundance for
additional genes is affected in the Pysap1(-) sporozoites
as we have shown here for the uncharacterized UIS2 and
UIS28. Clearly, lack of UIS genes expression cannot be
attributed to a defect in salivary gland invasion and resi-
dence as Pysap1(-) sporozoites infected the salivary
glands with efficiencies that are comparable to WT
sporozoites. Therefore, it appears likely that the reduction
of UIS transcript expression in Pysap1(-) sporozoites is a
direct effect of the lack of SAP1 and not an indirect effect
of an altered biological behaviour of the Pysap1(-)
mutants. Transcript abundance in eukaryotes is mainly
regulated by transcriptional and post-transcriptional
mechanisms. PySAP1 localization to the sporozoite cyto-
plasm and absence from the sporozoite nucleus suggests
that PySAP1 is involved in as-yet-to-be-deﬁned post-
transcriptional mechanisms of UIS transcript regulation,
as post-transcriptional regulation is expected to be
executed in the cytoplasm of the cell (Elemento et al.,
2007; Parker and Sheth, 2007). However, the C-terminus
of PySAP1, which is recognized by the antisera, might be
processed and left in the cytoplasm. In this scenario, the
remaining part of the protein might translocate to the
nucleus, where it might exert its effect by contributing to
the regulation of transcription of UIS genes. Interestingly,
post-transcriptional, but not transcriptional, regulation has
been hypothesized to be the main pathway for controlling
the expression levels of proteins in Plasmodium (Coulson
et al., 2004; Hakimi and Deitsch, 2007). Indeed, it has
been suggested that Plasmodium must rely on this
mechanism for controlling the extensive differential gene
expression required during the complex malaria parasite
life cycle (Hall et al., 2005). Recently, it has been shown
that a RNA helicase termed DOZI (Development of
Zygote Inhibited) is expressed in the female gametocyte
where it localizes to cytoplasmic protein complexes and is
involved in translational repression of transcripts (Mair
et al., 2006). DOZI knockouts showed a severe reduction
in the levels of many sexual stage-speciﬁc transcripts,
presumably because they were subject to rapid degrada-
tion when not protected in ribonucleoprotein (RNP)
complexes. We speculate that SAP1 might be an essen-
tial component of such an RNP complex in sporozoites
and protects UIS transcripts speciﬁcally from degradation.
This scenario however requires further investigation.
Interestingly, proteins with glutamine and asparagine-rich
domains have recently been shown to be part of RNP
complexes in yeast where they act as scaffolding proteins
(Decker et al., 2007).
Pysap1(-) sporozoites showed complete attenuation of
liver infection. This is clearly attributable to the lack of the
essential proteins UIS3, UIS4 and P52 and possibly addi-
tional UIS in the knockout parasite and likely not to a
lack of a direct effector function of PySAP1. Single-
and double-gene-deletion sporozoites are effective live
attenuated vaccines in mouse models (reviewed in
Mikolajczak et al., 2007b) and we have shown herein that
Pysap1(-) sporozoites also confer sterile long-lasting pro-
tection against PyWT sporozoite challenge. P. falciparum
gene deletion mutants might go forward for testing as
human malaria vaccines (Renia et al., 2006). We suggest
that a putative P. falciparum sap1(-) sporozoite may be an
attractive live attenuated vaccine candidate due to its
quasi-multilocus attenuation. Together, our data give initial
insights into the regulation of malaria parasite infectivity
after mosquito transmission and these ﬁndings might
advance efforts to develop measures for prevention of
malaria infection.
Experimental procedures
Experimental animals, parasites and cell lines
Six- to 8-week-old female BALB/cJ (for in vivo infection
studies and immunizations) or Swiss Webster (SW) mice (for
parasite cycle maintenance) were purchased from the
Jackson Laboratory (Bar Harbor, ME) or Harlan (Indianpolis,
IN). Animal handling was conducted according to Institutional
Animal Care and Use Committee-approved protocols. Wild-
type P. yoelii 17XNL(non-lethal strain) clone 1.1 (Weiss et al.,
1989 ) and Pysap1(-) parasites were cycled between SW
mice and Anopheles stephensi mosquitoes. Infected mosqui-
toes were maintained on sugar water at 24°C and 70%
humidity. Salivary gland sporozoites were extracted from
infected mosquitoes between days 13 and 15 post blood
meal infection as described before (Labaied et al., 2007;
Tarun et al., 2007). The human hepatoma cell line HepG2-
CD81 (Silvie et al., 2006) was used for all in vitro assays and
was maintained in DMEM-F12 medium supplemented with
antibiotics and 10% fetal calf serum (FCS).
Generation of Pysap1(-) parasites
Targeted deletion of PySAP1 by double-cross-over homolo-
gous recombination was achieved constructing a replace-
ment plasmid in the b3D.DT.H Db targeting vector (Janse
et al., 2006; Jongco et al., 2006). P. yoelii 17XNL genomic
DNA (gDNA) was used as a template to amplify a 1.5 kb
fragment of the 5′UTR of PySAP1 using oligonucleotide
primers PySAP1rep1 forward (F) and PySAP1rep2 reverse
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fragment was inserted into the transfection plasmid between
KpnI and HindIII restriction enzymes sites. Similarly, a 1 kb
DNA fragment from the 3′ORF sequence of PySAP1 was
ampliﬁed using PySAP1rep3F and PySAP1rep4R primers
and inserted between the SpeI and SacII restriction sites in
the transfection vector. The resulting plasmids were digested
with KpnI and SacII to release the replacement fragment
used for the transfection. Transfection of P. yoelii 17XNL
parasites using the Amaxa nucleofector device (Amaxa
GmbH, Germany), resistant parasites selection and recom-
binant parasite cloning by serial limiting dilutions were all
conducted as described elsewhere (Janse et al., 2006;
Jongco et al., 2006). We obtained two independent
Pysap1(-) clonal parasite populations that were phenotypi-
cally identical. Detailed analysis was performed with one
representative clone. To conﬁrm the targeted deletion and the
new genetic recombination, integration-speciﬁc gDNA PCR
ampliﬁcation of the Pysap1(-) locus was generated using the
speciﬁc primers combinations Test1 (TgF and PySAP1TestR)
and Test2 (PySAP1TestF and TgR) (primers sequences
provided in Table S2). Whereas PySAP1 locus-speciﬁc
gDNA-PCR ampliﬁcation was generated using the primers
combination WT (PySAP1orfF and PySAP1orfR), the primers
combination test for the WT PySAP1 locus was also used in
RT-PCR to conﬁrm the absence of the PySAP1 transcript
from Pysap1(-) recombinant parasite clone.
Reverse transcription polymerase chain reaction
(RT-PCR)
Total RNA was extracted using TRIzol reagent (Invitrogen)
and treated with TURBO DNase (Ambion) from P. yoelii sali-
vary gland sporozoites (2 ¥ 10
6), oocyst sporozoites (2 ¥ 10
6)
or mixed blood stages (1 ¥ 10
7 infected red blood cells were
isolated from an infected mouse by heart puncture bleeding
and serial limiting dilution of infected blood). P. falciparum
sporozoites and mixed blood-stage RNA materials were
kindly provided by Dr Urszula Krzych and Dr Jack Williams
(WRAIR, Silver Spring, MD). cDNA synthesis was performed
using the Super Script III Platinum two-step qRT-PCR kit
(Invitrogen). The sequences of speciﬁc primers used for
ampliﬁcation from cDNAare listed in Table S2.All PCR ampli-
ﬁcation cycles were performed at 95°C for 30 s for DNA
denaturation, 55°C for 30 s for primer annealing, 60°C for
4 min for DNA strands extension.
Immunoﬂuorescence assays (IFAs)
We generated rabbit polyclonal antiserum against a
PySAP13020-3034 synthetic peptide (LRGRQVQQSFNHSAS).
The antiserum was further affinity-puriﬁed against the syn-
thetic peptide and the speciﬁc IgGs were concentrated.
Pysap1(-) or PyWT sporozoites were air dried on poly-lysine-
treated glass slides after incubation for 1 h at 37°C. Sporo-
zoites were ﬁxed with 4% paraformaldehyde (PFA) for 10 min
at room temperature. This was followed by permeabilization
with 0.2% saponin for 15 min at room temperature. After
blocking in 10% FCS/PBS overnight (ON) at 4°C, primary
antibodies were diluted 1:300 in 10%FCS/PBS and incubated
with the sporozoites for 1 h at 37°C. Mouse monoclonal anti-
bodies 2F6 (Potocnjak et al., 1980; Yoshida et al., 1980 )
and 2E6 (Tsuji et al., 1994 ) were used against PyCSP and
PyHSP70, respectively, and rabbit polyclonal antisera against
PySAP1, PyUIS4, PyUIS3, PyMTIP were used in sporozoite
IFAs. Alexa Fluor (Molecular Probes, Eugene, OR) conju-
gated secondary antibodies were also diluted in 10%FCS/
PBS and incubated with the sporozoites for 1 h at 37°C.
Conjugated anti-rabbit Alexa Fluor 488 (green) and anti-
mouse Alexa Fluor 594 (red) were used to visualize the
bound primary antibodies. Nuclear staining with 4′,6′-
diamidino-2-phenylindole (DAPI) was conducted within the
last washing step with PBS (1:2000) and before mounting the
slides with an antifade reagent (Fluoroguard; Bio-Rad, Her-
cules, CA). Preparations were analysed using ﬂuorescence
confocal microscopy (Olympus 1 ¥ 70 Delta Vision).
Mouse infections and immunizations
For sporozoite immunizations and challenges, BALB/cJ mice
were injected iv with sporozoites re-suspended in incomplete
DMEM-F12 medium. Blood-stage patency was monitored
daily by evaluation of Giemsa-stained blood smears from day
2 to day 14 post sporozoite infection. For blood-stage chal-
lenge experiments, immunized mice that had been chal-
lenged with sporozoites twice were injected either ip with 10
6
or iv with 10
3PyWT erythrocytic asexual stages in RPMI.
PyWT blood stages were isolated from an infected mouse by
heart puncture followed by serial limited dilution.
Cell-traversal assay
Hepatoma HepG2-CD81 cells were inoculated in eight-well
chamber slides at a density of 60 000 cells well
-1 2 days
before the assay. A total of 20 000 sporozoites per well of
PyWT or Pysap1(-), in addition to uninfected mosquitoes
salivary gland extracts (mock), were re-suspended in incom-
plete DMEM-F12 medium with 3% bovine albumin serum
(BSA) and 2 mg ml
-1 ﬂuorescein isothiocyanate (FITC)-
dextran (Invitrogen-Molecular Probes, Eugene, OR). Sporo-
zoites and mock suspensions were added to the cells,
centrifuged for 2 min at 1000 r.p.m. and incubated for 1 h at
37°C. Thereafter, the cells were washed thoroughly with PBS
and complete DMEM medium twice to remove any extracel-
lular dextran, and the cells were allowed to grow for a further
3 h in complete DMEM medium. Flow cytometric quantitative
analysis of dextran-positive cells was conducted using a ﬂow
cytometer (Cytopia, Seattle, WA) and the ﬂow cytometry
analysis program FlowJo version 7.0.3 (TreeStar, Ashland,
OR) (Labaied et al., 2007).
In vitro infection assays
We standardized a differential permeabilization hepatoma
infectionassaytospeciﬁcallyquantifyliver-stagesparasitesat
different time points of infection by ﬂuorescence microscopy.
Hepatoma HepG2-CD81 cells were seeded in eight-well
chamber slides at a density of 40 000–50 000 cells well
-1
2 days before the assay. A total of 50 000 sporozoites of
Pysap1(-) or PyWT re-suspended in incomplete DMEM-F12
mediumwereaddedperwell.Thesporozoiteswereincubated
for 1 h with the cells at 37°C. The cells were washed with PBS
and with complete DMEM F12 media twice to remove all
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Onehourpostinfectionassayswereﬁxedwith4%PFA(which
does not permeabilize hepatocytes) for 10 min at room tem-
perature, followed by permeabilization (or not) with ice-cold
methanol for 5 min at room temperature and then blocking in
10%FCS/PBS (ON) at 4°C. The cells for other post-infection
time points assays were further grown in complete DMEM
medium until ﬁxed, permeabilized (or not) and blocked at 6 h,
12 h, 18 h and 24 h. Primary antibodies against PyCSP,
PyHSP70 and PyUIS4 were diluted to 1:300 in 10%FCS/PBS
and incubated with the cells for 1 h at 37°C. Conjugated
secondary anti-mouseAlexa Fluor 488 (green) and anti-rabbit
AlexaFluor594(red)wereusedtovisualizetheboundprimary
antibodies. Nuclear staining with DAPI (1:3000 diluted) was
performed with the last wash and before mounting the slides
with an antifade reagent. Preparations were analysed using
ﬂuorescence confocal microscopy (Olympus 1 ¥ 70 Delta
Vision). Intracellular parasites were determined as the total
number of parasites counted in each permeabilized sample
wellasafractionofthetotalnumberofparasitescountedinthe
control unpermeabilized sample well.
Transmission electron microscopy
For thin-section transmission electron microscopy, 10
6 PyWT
and Pysap1(-) sporozoites were used to infect 10
6 subcon-
ﬂuent HepG2-CD81 cells. One hour post infection, cells were
ﬁxed with 2.5% glutaraldehyde (Electron Microscopy
Sciences, Hatﬁeld, PA) in 0.1 M sodium cacodylate buffer
(pH 7.4) for 1 h at room temperature and processed as
described previously (Quittnat et al., 2004), before examina-
tion with a Philips 410 electron microscope (Eindhoven, the
Netherlands) under 80 kV.
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